NOCIL
NOCIL share price & financials
- Price
- ₹162.7
- Market cap
- ₹2.8k Cr
- Sector
- Chemicals
- Calls analysed
- 8
NOCIL Limited Q1 FY27
What went well
- Revenue from operations of ₹403 crores, up 20% YoY, driven by growing volumes and increased selling prices.
- Healthy 9% YoY volume growth, with double-digit domestic growth and single-digit export growth.
- Operating EBITDA of ₹45 crores, up 48% YoY and 115% QoQ.
What to watch
- Moderate 3% QoQ volume decline due to temporary supply-side constraints (utilities, logistics) and geopolitical situation.
- Temporary demand contraction in the non-tyre segment due to lower production, sharp increase in input costs, and labor shortage.
What NOCIL Limited does
NOCIL Limited, part of the Arvind Mafatlal Group, is India's largest manufacturer of rubber chemicals, with over four decades of experience in the business. It makes accelerators, anti-oxidants/anti-degradants and other specialty additives used in tyres, automotive components, industrial rubber goods, footwear, hoses and gloves, manufactured at its facilities in Navi Mumbai (operating since 1976) and Dahej, Gujarat (operating since 2013). It sells to tyre majors and rubber processors, both domestic and international, across more than 40 countries, supported by an in-house R&D centre and a Marketing Technical Services (MTS) team that provides technical support to customers.
Segments
- Rubber Chemicals
- Market position
- Largest rubber chemicals manufacturer in India
- Manufacturing facilities
- 2 (Navi Mumbai, Maharashtra — since 1976; Dahej, Gujarat — since 2013)
- Product varieties
- 20+ rubber chemical product varieties
- Country presence
- 40+ countries
- Business track record
- Over 4 decades of experience in the rubber chemicals business
- Ongoing capacity project
- Brownfield expansion of the TDQ antioxidant line at the Dahej facility, targeted for commissioning in 2026-27
Guidance record · Q1 FY27
what the last two calls moved 19 tracked 3 delivered 5 missed 11 open- New Product Commercial Launch delayed said Q2 FY26 Promised: Active commercial sales to start before the end of FY26 Q1 FY27: No specific update provided on the commercial launch status. Management focus has shifted to the new TDQ plant's revenue timeline.
- FY27 Volume Growth diluted said Q3 FY26 Promised: Double-digit growth in FY27 Q1 FY27: YoY volume growth was 9%. Management revised guidance for FY27 to 'Around 10%', which is a dilution from the original 'double-digit' target.
- Dahej Capex Commissioning delivered said Q2 FY25 Promised: Plant ready by Sep '26, business contribution from Q4 FY27 Q4 FY26: The TDQ capex at Dahej has been completed, and we have commenced trial production. This is ahead of the original 'Sep '26' schedule.
All 19 tracked — every revision, and every one management stopped mentioning.
Open the guidance ledgerQuarterly results
Q1 FY27: revenue up 19.9%, net profit up 64.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 363 | 318 | 340 | 336 | 321 −12% | 316 −1% | 330 −3% | 403 +20% |
| EBITDA | 38 | 24 | 34 | 31 | 22 −42% | 27 +13% | 21 −38% | 45 +45% |
| Net profit | 42 | 13 | 21 | 17 | 12 −71% | 9 −31% | 17 −19% | 28 +65% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance +1.8% 1Y
1Y: ₹186.23 on 10 Sept 2025 → ₹189.65. High ₹195.31 (10 Sept 2026), low ₹128.23 (23 Jan 2026).
How the price took the results
close before → close after
- Q1 FY27
- −1.8%
- 4 Aug
- Q4 FY26
- −3.4%
- 8 May
- Q3 FY26
- +3.2%
- 12 Feb
- Q2 FY26
- −2.1%
- 3 Nov
The move from the last close before each results date to the first close after it — the market's first read on the quarter, not the quarter itself.
Financials, as filed
Revenue fell 6.9% a year over 3 years, FY23 to FY26. Operating margin narrowed to 7.8%.
| Year ending | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|
| Revenue | ₹1.6k Cr | ₹1.4k Cr | ₹1.4k Cr | ₹1.3k Cr |
| Operating profit | ₹253 Cr | ₹195 Cr | ₹137 Cr | ₹101 Cr |
| Operating margin | 15.6% | 13.5% | 9.8% | 7.8% |
| Interest | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹0 Cr |
| Depreciation | ₹56 Cr | ₹52 Cr | ₹53 Cr | ₹56 Cr |
| Net profit | ₹149 Cr | ₹133 Cr | ₹103 Cr | ₹55 Cr |
| Net margin | 9.2% | 9.2% | 7.4% | 4.2% |
| Cash from operations | ₹282 Cr | ₹201 Cr | ₹26 Cr | ₹252 Cr |
| Free cash flow | ₹253 Cr | ₹184 Cr | ₹-95 Cr | ₹84 Cr |
| ROCE | 13.0% | 10.0% | 6.0% | 4.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹166 Cr | ₹167 Cr | ₹167 Cr | ₹167 Cr | ₹167 Cr | ₹167 Cr |
| Reserves | ₹1.1k Cr | ₹1.3k Cr | ₹1.4k Cr | ₹1.5k Cr | ₹1.6k Cr | ₹1.6k Cr |
| Borrowings | ₹6 Cr | ₹6 Cr | ₹10 Cr | ₹13 Cr | ₹9 Cr | ₹8 Cr |
| Other liabilities | ₹324 Cr | ₹380 Cr | ₹295 Cr | ₹304 Cr | ₹291 Cr | ₹329 Cr |
| Total liabilities | ₹1.6k Cr | ₹1.8k Cr | ₹1.9k Cr | ₹2.0k Cr | ₹2.1k Cr | ₹2.1k Cr |
| Fixed assets | ₹918 Cr | ₹909 Cr | ₹888 Cr | ₹870 Cr | ₹834 Cr | ₹831 Cr |
| Capital work in progress | ₹14 Cr | ₹8 Cr | ₹9 Cr | ₹16 Cr | ₹176 Cr | ₹221 Cr |
| Investments | ₹68 Cr | ₹53 Cr | ₹218 Cr | ₹399 Cr | ₹408 Cr | ₹415 Cr |
| Other assets | ₹614 Cr | ₹859 Cr | ₹742 Cr | ₹730 Cr | ₹654 Cr | ₹645 Cr |
| Total assets | ₹1.6k Cr | ₹1.8k Cr | ₹1.9k Cr | ₹2.0k Cr | ₹2.1k Cr | ₹2.1k Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, DIIs added +2.28 pp while FIIs trimmed −1.87 pp. The shareholder count shrank 3% to 1,61,342.
- Promoters
- 33.8%
- FIIs
- 4.8%
- DIIs
- 7.5%
- Public
- 54.0%
Since Jun 2025
- DIIs +2.28 pp
- FIIs −1.87 pp
- Public −0.40 pp
How it drifted, 12 quarters
Over this window DIIs went from 3.6% to 7.5% — +3.9 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 33.8%, FIIs 6.4%, DIIs 3.6%, Public 56.2%.Dec '23: Promoters 33.8%, FIIs 7.0%, DIIs 2.8%, Public 56.4%.Mar '24: Promoters 33.8%, FIIs 7.8%, DIIs 3.5%, Public 54.9%.Jun '24: Promoters 33.8%, FIIs 7.8%, DIIs 4.4%, Public 54.0%.Sep '24: Promoters 33.8%, FIIs 7.9%, DIIs 6.1%, Public 52.2%.Dec '24: Promoters 33.8%, FIIs 7.8%, DIIs 5.9%, Public 52.5%.Mar '25: Promoters 33.8%, FIIs 8.2%, DIIs 5.3%, Public 52.8%.Jun '25: Promoters 33.8%, FIIs 6.7%, DIIs 5.2%, Public 54.4%.Sep '25: Promoters 33.8%, FIIs 5.2%, DIIs 6.6%, Public 54.5%.Dec '25: Promoters 33.8%, FIIs 4.5%, DIIs 6.5%, Public 55.3%.Mar '26: Promoters 33.8%, FIIs 4.5%, DIIs 7.9%, Public 53.8%.Jun '26: Promoters 33.8%, FIIs 4.8%, DIIs 7.5%, Public 54.0%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- ICICI Prudential Children'S Fund Mutual fund newly disclosed 2.55% held
- Mahindra Manulife Small Cap Fund Mutual fund +1.18 pp 3.57% held
- Hrishikesh Arvind Mafatlal newly disclosed 0.47% held
- Tejas Balchandra Trivedi +0.19 pp 2.82% held
The same filing shows 0 holders trimming and 2 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of NOCIL Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| HRISHIKESH ARVIND MAFATLAL (as a Trustee of Gurukripa Trust) | 18.16% | unchanged |
| Mafatlal Industries Limited | 15.12% | unchanged |
| Mahindra Manulife Small Cap Fund Mutual fund | 3.57% | +1.18 pp |
| Tejas Balchandra Trivedi | 2.82% | +0.19 pp |
| ICICI Prudential Children'S Fund Mutual fund | 2.55% | newly disclosed |
| Nilesh Kishor Shah | 1.74% | unchanged |
| Iepf | 1.31% | unchanged |
| Aagam Agencies Pvt Ltd | 1.13% | unchanged |
| Prashant Jain | 1.12% | unchanged |
| Hrishikesh Arvind Mafatlal | 0.47% | newly disclosed |
| Priyavrata Mafatlal | 0.01% | unchanged |
| HRISHIKESH ARVIND MAFATLAL (as a Trustee of Narsingha Trust) | 0.00% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹190, this stock must grow earnings at 35% every year for 7 years. Our analysis caps realistic growth at ~-28%. At that growth it is worth ₹7 — downside of 96%.
- Growth the price implies
- 34.6% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -28.2% a year
- net profit, FY23–FY26 · EPS -28.1%
- The gap
- 0.6 pp
- -96% downside if it only repeats history
All earnings calls (8)
Read the Q1 FY27 call →Learn to analyse NOCIL Limited
Guides on how to read this kind of business and the numbers that matter.